Melanoma patients choose: shot or IV? new study seeks preferences

NCT ID NCT06101134

First seen Apr 13, 2026 · Last updated May 13, 2026 · Updated 3 times

Summary

This study looks at whether people with melanoma prefer getting their cancer medicine as a shot under the skin or through an IV drip. About 100 participants will try both methods and report which they like better. The goal is to make treatment more convenient and comfortable.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Local Institution - 0003

    San Pedro Alcántara, Málaga, 10002, Spain

  • Local Institution - 0004

    Torino, TO, 10126, Italy

  • Local Institution - 0005

    Concepción, 4070196, Chile

  • Local Institution - 0006

    Seville, 41013, Spain

  • Local Institution - 0007

    Anchorage, Alaska, 99508-2974, United States

  • Local Institution - 0008

    Piraeus, 185 47, Greece

  • Local Institution - 0009

    Cartagena, MU, 30120, Spain

  • Local Institution - 0010

    San Francisco, California, 94115-3010, United States

  • Local Institution - 0011

    Barcelona, B, 08025, Spain

  • Local Institution - 0012

    Padova, PD, 35128, Italy

  • Local Institution - 0013

    Phoenix, Arizona, 85054-4502, United States

  • Local Institution - 0014

    Athens, I, 115 27, Greece

  • Local Institution - 0015

    Las Condes, Santiago Metropolitan, 8331010, Chile

  • Local Institution - 0017

    Bergamo, BG, 24127, Italy

  • Local Institution - 0018

    Milan, MI, 20141, Italy

  • Local Institution - 0019

    Thessaloniki, B, 546 22, Greece

  • Local Institution - 0020

    Badalona, 08916, Spain

  • Local Institution - 0021

    Roma, RM, 00144, Italy

  • Local Institution - 0022

    Barcelona, B, 08908, Spain

  • Local Institution - 0023

    Holargos, Athens, 155 62, Greece

  • Local Institution - 0026

    Naples, 80131, Italy

  • Local Institution - 0027

    Cantabria, 39008, Spain

  • Local Institution - 0028

    Albuquerque, New Mexico, 87106, United States

  • Local Institution - 0029

    Marousi, I, 151 25, Greece

  • Local Institution - 0030

    Seattle, Washington, 98104, United States

  • Local Institution - 0032

    Edgewood, Kentucky, 41017, United States

  • Local Institution - 0033

    Thessaloniki, 564 29, Greece

  • Local Institution - 0034

    Atlanta, Georgia, 30342, United States

  • Local Institution - 0035

    Meldola, FC, 47014, Italy

  • Local Institution - 0036

    Issaquah, Washington, 98026, United States

  • Local Institution - 0037

    Edmonds, Washington, 98026-8032, United States

Conditions

Explore the condition pages connected to this study.